4th Annual Global Clinical Outsourcing Forum

17 - 19 September, 2013

Amsterdam, The Netherlands


  • Follow us on
  • twitter
  • linkedin
  • facebook

Resource Center

Download the Agenda

Ebook: Industry Report

Ebook: Industry Report

Featured Speakers

Mark Fowler
Head of Strategic Outsourcing Europe
Takeda
Diane Chisholm
Head of Clinical Operations
Santhera Pharmaceuticals AG
Ruud Brands
Chief Executive Officer
Alloksys Life Sciences BV
Kristof Vercruysse
Director Clinical Operations
Ablynx NV

Become a win-win negotiator and streamline your RFP process:

Our two interactive workshops show you how!

Quick Links

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!


Sponsors & Exhibitors
Media Partners

“This wasn’t a conference; it was a shared experience – with complete interaction throughout” DELEGATE 2013

You’ve been to the large tradeshow events that outline the complex challenges of outsourcing your clinical trials. You’ve heard the PowerPoint presentations. Now is your opportunity to get under the skin of the issues presented and collaborate with your Clinical Outsourcing peers to focus on solutions.

Building on the huge success of last year’s completely interactive forum, Global Clinical Outsourcing Forum 2013 completely transforms the standard conference format, moving away from presentations that “tow the company line”. This is your unique forum to have an honest and open exchange with those who understand your challenges the most.

Pull up a chair and join the discussion:

  • Streamlining study start up: What activities can be run in parallel, avoided or delayed that may make start-up more efficient? Diane Chisholm, Head of Clinical Operations, Santhera Pharmaceuticals Ltd explores start up metrics and more
  • Optimising your protocol design when faced with increasing complexities: Paul Bouten, Outsourcing and Contracts Manager, Boston Scientific leads a discussion on what models exist for successful partnering on protocol design
  • Setting up a robust communication plan between sponsor and CRO: a lively panel debate including representatives from Pfizer and MSD share tried and tested approaches
  • Implementing vendor management mechanisms to reinforce quality in a resource-challenged environment: Gain insight into how your peers are implementing an effective vendor/CRO oversight model –in a roundtable led by Jenny de Gelder Bakker, Compliance Oversight Lead, Pfizer, Ilaria di Resta, Head of Clinical Operations, Novimmune and Ilsa Morlan Fernandez, Trial Manager, MSD

Other key themes for discussion include:

  • How to minimise scope and creep
  • Vendor oversight strategies
  • Measuring partner performance and setting KPIs
  • Why do clinical partnerships fail
  • Best practice approaches to securing alliances and strategic partnerships no matter what size your business is or where you are operating

See the programme for full details